$CO_2$ Laser Resurfacing in Skin Tumor Surgery

피부암 절제술과 동시에 시행한 레이저 박피술

  • Jang, Ju-Yun (Department of Plastic and Reconstructive Surgery, Dankook University College of Medicine) ;
  • Oh, Sang-Ah (Department of Plastic and Reconstructive Surgery, Dankook University College of Medicine) ;
  • Lee, Sung-Hwan (Department of Plastic and Reconstructive Surgery, Dankook University College of Medicine) ;
  • Kang, Dong-Hee (Department of Plastic and Reconstructive Surgery, Dankook University College of Medicine)
  • 장주윤 (단국대학교 의과대학 성형외과학교실) ;
  • 오상아 (단국대학교 의과대학 성형외과학교실) ;
  • 이성환 (단국대학교 의과대학 성형외과학교실) ;
  • 강동희 (단국대학교 의과대학 성형외과학교실)
  • Received : 2009.08.11
  • Accepted : 2010.01.11
  • Published : 2010.03.10

Abstract

Purpose: The prevalence of skin cancers and cutaneous premalignant lesions are increasing recently. It is necessary to treat cutaneous premalignant lesions, because these can progress to invasive skin cancers. We conducted a retrospective study to evaluate the usefulness of $CO_2$ laser resurfacing in skin tumor surgery. Methods: From 2005 to 2008, 14 patients with skin cancers, photodamaged skin and cutaneous premalignant lesions were treated with skin cancer excision, immediate reconstruction, and $CO_2$ facial laser resurfacing. Mean average follow-up period was 15.6 months (5 months - 36 months). Biopsy and clinical photograph were taken preoperatively, intraoperatively and through follow-up period to assess the effectiveness of laser resurfacing. Recurrence and side effects were evaluated through follow-up period. Results: Histologic examination shows the abolition of actinic atypia, regeneration of epidermis and normalization of cellular differentiation after laser resurfacing. Clinical photographs shows elimination of keratoses and spots, and the homogeneous, smoothening change of skin surface, indicating healthy and younger faces. All patients had remained free of skin cancers and premalignant lesions in laser-treated field through follow-up period. Conclusion: $CO_2$ laser resurfacing in skin tumor surgery can treat not only premalignant lesions but also subclinical lesions of photodamaged skin. Moreover it may be helpful in prophylaxis against skin cancers and premalignant lesions, providing rejuvenation and cosmetic improvement.

Keywords

References

  1. Moon SE, Cho KH, Hwang JH, Kim JA, Youn JI: A statistical study of cutaneous malignant tumors. Korean J Dermatol 36: 7, 1998
  2. Lee BG, Yoon TY: A histopathological study of accompanying actinic keratosis and bowen's disease at the periphery or within the confines of cutaneous squamous cell carcinoma. Korean J Dermatol 39: 1100, 2001
  3. Marks R, Rennie G, Selwood T: The relationship of basal cell carcinomas and squamous cell carcinomas to solar keratoses. Arch Dermatol 124: 1039, 1998
  4. Iyer S, Friedli A, Bowes L, Kricorian G, Fitzpatrick RE: Full face laser resurfacing: Therapy and prophylaxis for actinic keratoses and non-melanoma skin cancer. Lasers Surg Med 34: 114, 2004 https://doi.org/10.1002/lsm.20012
  5. Covadonga Martinez-Gonzalez M, del Pozo J, Paradela S, Fernandez-Jorge B, Fernandez-Torres R, Fonseca E: Bowen's disease treated by carbon dioxide laser. A series of 44 patients. J Dermatolog Treat 19: 293, 2008 https://doi.org/10.1080/09546630701870772
  6. Marcil I, Stern RS: Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: A critical review of the literature and meta-analysis. Arch Dermatol 136: 1524, 2000 https://doi.org/10.1001/archderm.136.12.1524
  7. Chen GJ, Feldman SR, Williford PM, Hester EJ, Kiang SH, Gill I, Fleischer AB Jr: Clinical diagnosis of actinic keratosis identifies an elderly population at high risk of developing skin cancer. Dermatol Surg 31: 43, 2005 https://doi.org/10.1097/00042728-200501000-00009
  8. Lubritz RR, Smolewski SA: Cryosurgery cure rate of actinic keratoses. J Am Acad Dermatol 7: 631, 1982 https://doi.org/10.1016/S0190-9622(82)70143-4
  9. Lawrence N, Cox SE, Cockerell CJ, Freeman RG, Cruz PD Jr: A comparison of the efficacy and safety of Jessner's solution and 35% trichloroacetic acid vs 5% fluorouracil in the treatment of widespread facial actinic keratoses. Arch Dermatol 131: 176, 1995 https://doi.org/10.1001/archderm.131.2.176
  10. Cox NH, Eedy DJ, Morton CA: Guidelines for management of Bowen's disease: 2006 update. Br J Dermatol 156: 11, 2007 https://doi.org/10.1111/j.1365-2133.2006.07610.x
  11. Tantikun N: Treatment of Bowen's disease of the digit with carbon dioxide laser. J Am Acad Dermatol 43: 1080, 2000 https://doi.org/10.1067/mjd.2000.109841
  12. Trimas SJ, Ellis DA, Metz RD: The carbon dioxide laser: An alternative for the treatment of actinically damaged skin. Dermatol Surg 23: 885, 1997 https://doi.org/10.1016/S1076-0512(97)00288-4
  13. Massey RA, Eliezri YD: A case report of laser resurfacing as a skin cancer prophylaxis. Dermatol Surg 25: 513, 1999 https://doi.org/10.1046/j.1524-4725.1999.08260.x
  14. Fulton JE, Rahimi AD, Helton P, Dahlberg K, Kelly AG: Disappointing results following resurfacing of facial skin with $CO_{2}$ lasers for prophylaxis of keratoses and cancers. Dermatol Surg 25: 729, 1999 https://doi.org/10.1046/j.1524-4725.1999.99035.x
  15. Hantash BM, Stewart DB, Cooper ZA, Rehmus WE, Koch RJ, Swetter SM: Facial resurfacing for nonmelanoma skin cancer prophylaxis. Arch Dermatol 142: 976, 2006 https://doi.org/10.1001/archderm.142.8.976